refusal of VTE prophylaxis doses is the most common documented reason these doses are not administered. A small number of patients and nursing units account for a vast majority of refused doses. We have initiated a mixed-methods investigation to determine what patient, nursing unit, and culture of care-level factors may explain refusal of these doses.
OBJECTIVES:
To assess the impact of pharmacist-led face-to-face counseling on prescription first refill rate in patients who are new to statins or thyroid medications. METHODS: A retrospective pre-post with case-control cohort study design was employed. In May 2010, two community pharmacies implemented face-to-face counseling by trained pharmacists at the site of care when patients initially filled their statin or thyroid prescriptions. Patients' first refill rate, defined as percentage of patients who refilled their prescriptions within a two-week's period after exhaustion of their initial fill, was assessed as the primary outcome measure. Similar computations were performed for patients' who filled their study medications at the two stores, 12-months prior to the intervention program. Additionally, two control pharmacy stores were selected based on pharmacy type, operational years of stores, prescription volume, and corresponding population characteristics. Refill rates in the pre and post-periods were also computed for control stores. A chi-square test was performed to investigate the relationship between face-to-face intervention and patients' first refill rate. RESULTS: Test stores that implemented face-to-face counseling, conducted interventions on 81 new to therapy patients in the post period, while a total of 76 (new to therapy patients) were included in the pre-period. A total of 73 and 81 new to therapy patients were selected from control stores in the pre and post-period respectively. For test stores, chi-square analyses showed a significant increase in the refill rates in the postperiod as compared to the pre-period (Pre-period: 55.7% Vs Post-period: 70.4% pϽ0.01), whereas control stores did not show any significant increase across two periods (Pre-period: 56.2% Vs Post-period: 61.7%, pϾ0.05). CONCLUSIONS: Pharmacist-led face-to-face counseling had a positive impact on patient's refill behavior. The study showed an early impact of the program; additional larger pilot studies and longer follow-up period are needed to better understand the full benefit of the program. 
PCV70 VARIATIONS IN THE IMPACT OF ILLNESS PERCEPTIONS AND MEDICATION BELIEFS ON MEDICATION COMPLIANCE OF ELDERLY VERSUS GERIATRIC HYPERTENSIVE COHORTS: A COMPARATIVE ANALYSIS

METHODS:
A cross-sectional research design, utilizing convenience sampling strategies and self-administered surveys of elderly hypertensive residents living in New York City senior care centers (Nϭ117). Medication compliance was measured using Morisky's test; medication beliefs were measured using Beliefs about Medication Questionnaire (BMQ), and illness perceptions using Brief Illness Perceptions Questionnaire (BIPQ). RESULTS: MajoriMajority of the population was white (75%). There were no significant differences observed demographically between the elderly (55-65 years) and geriatric (65ϩ years) samples except with respect to college education (53% vs. 47%). About 46% of the elderly sample was noncompliant with hypertension medications, compared to 63% who were 65 years and older (geriatric). BIPQ component scores correlated positively with medication compliance score across both elderly and geriatric samples (rϭ 0.134; pϭ0.496 and rϭ 0.447; pϭ0.000, respectively). The score on Specific Necessity Beliefs dimension associated positively with Morisky's Test score across both the cohorts (rϭ0.027, pϭ0.892 and rϭ0.297; pϭ0.020), whereas General Harm and General Overuse Beliefs about medication correlated negatively with medication compliance. A majority of the participants rank-ordered stress as the number one cause of their illness (49.1%), followed by 'lifestyle' (43.8%) and 'hereditary factors' (7.1%). CONCLUSIONS: Medication noncompliance seems to worsen with an increase in age. Stronger necessity beliefs and more favorable perceptions about the illness are observed in geriatrics compared to elderly. The study underscores the importance of incorporating patient perceptions about illness and medication beliefs into disease management frameworks that seek to build medication compliance in hypertension. 
PCV71 EVALUATING MEDICATION ADHERENCE WITH CHRONIC CARDIOVASCULAR THERAPIES AMONG UNINSURED WORKING ADULTS: RESULTS FROM THE TEXAS DEMONSTRATION TO MAINTAIN INDEPENDENCE AND EMPLOYMENT (DMIE) STUDY
OBJECTIVES:
To examine patterns of medication adherence and persistence with antihypertensive or statin therapies among uninsured working-adults enrolled in the Texas DMIE Study. METHODS: This study was a randomized controlled trial (RCT) conducted to assess the effects of an intervention (i.e., improved medical services and subsidized drug-copay) among uninsured working-adult participants age 21-65 years, receiving medical services in the Harris County Health District. Cardiovascular medication adherence and persistence were measured separately for participants prescribed either statin or antihypertensive (i.e.,angiotensin-converting-enzyme-inhibitor or angiotensin-receptor-blocker) therapy during an 18month period. Medication adherence was calculated as the proportion of days covered (PDC). Participants were "adherent" when PDC Ն80%. Persistence was measured as a Ն35-day gap between drug refills. Logistic regression and cox proportional hazards models evaluated potential predictors of adherence and persistence. RESULTS: For participants on statin therapy (Nϭ449), a higher mean PDC (pϽ0.01) was observed in the intervention cohort (0.61[SDϭ0.27]) versus control (0.51[SDϭ.30]). Switching statins and titration adjustments were significant predictors of adherence. Adjusting for covariates, the intervention (ORϭ1.28[CI95%,1.01,2.68]) was more likely to be adherent to statins versus control. Mean persistence with statins in the intervention was 230-days compared to 171days for control group participants. The intervention was less likely to experience a refill gap (ORϭ0.69[CI 95%,0.51,0.92]) versus control. For antihypertensive drugs (Nϭ636), mean PDC in the intervention was 0.65 (SDϭ0.27) versus 0.60 ((SDϭ0.28) for control (pϽ0.02). Predictors of adherence included race/ethnicity, polypharmacy, and depression. The intervention group (ORϭ1.32[CI 95%,1.07,2.88]) was more likely to be adherent versus control. Mean persistence with antihypertensives in the intervention was 291-days versus 257-days for control. No significant difference in persistence seen between intervention and control. CONCLUSIONS: This RCT showed improved adherence to statin and antihypertensive medications among the intervention cohort. Findings from this study would be useful in guiding ongoing efforts to optimize cardiovascular-drug adherence targeted toward uninsured working-adults. 
PCV72 THE RISK OF STROKE AND PREVENTATIVE STEPS AMONG PATIENTS DIAGNOSED WITH ATRIAL FIBRILLATION IN THE UNITED STATES
OBJECTIVES:
This study examined stroke risk and prevention among US patients diagnosed with atrial fibrillation (AF). METHODS: Data were extracted from the US 2010 National Health and Wellness Survey, an annual, Internet-based, cross-sectional database of 75,000 adults (age Ͼϭ18). Stroke risk was assessed with CHADS 2 , determined by presence of congestive heart failure, hypertension, diabetes mellitus, old age (75 yearsϩ), and history of stroke or transient ischemic attack. Low-(CHADS 2 ϭ 0), moderate-(1), and high-(2ϩ) risk patients reported which steps, if any, they took to prevent stroke: low fat or low sodium diet, regular exercise, smoking cessation, weight loss, blood pressure or cholesterol reduction, or use of baby aspirin, aggrenox, warfarin, clopidogrel, or other medications. High-risk patients were compared with low and moderate-risk patients, adjusting for sociodemographic and health characteristics using logistic regression models. RESULTS: Among 1,350 respondents diagnosed with AF (projected US prevalence of 1.49%), 308 (22.8%) were low, 473 (35%) moderate, and 569 (42.2%) high in risk of stroke. High-vs. low-risk patients were significantly more likely to take any preventative steps (60.5% vs. 34.1%, respectively; ORϭ2.75, pϽ0.001) . Furthermore, high-risk patients were significantly more likely to take steps to lower their blood pressure (ORϭ8.33, pϽ0.001), cholesterol (ORϭ2.46, pϭ0.007), use clopidogrel (ORϭ7.46, pϭ0.027) or other stroke-prophylactic medications (ORϭ3.32, pϭ0.003) compared with low-risk patients. No differences were observed on lifestyle modification such as diet, exercise or smoking cessation. CONCLUSIONS: These results suggest, US adults at high risk of stroke are more likely to take steps to lower high blood pressure and cholesterol, and to use medications to prevent stroke, compared with low-risk individuals. No significant differences emerged on diet, regular exercise, smoking cessation and aspirin use. Higher risk correlated with higher prevention, yet there remains an unmet need for increased targeted treatment and lifestyle changes for high-risk AF patients.
PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPAN
Noto S 1 , Uemura T 2 , Izumi R 1 , Moriwaki K 1 1 Niigata University of Health and Welfare, Niigata, Japan, 2 Kyorin University, Tokyo, Japan OBJECTIVES: To assess the measurement properties and validity of Health Utilities Index Mark 3 (HUI3) Japanese version for stroke patients in Japan. METHODS: The HUI3 was administered 553 patients with stroke who were admitted in seven hospitals. Proxies of the patients completed Japanese version of the HUI3 questionnaires at start phase of rehabilitation. Patients were categorized using modified Rankin scale (MRS). The construct validity was assessed by analyzing the degree to which lower score on the HUI3 scores correlated positively with MRS. RESULTS: Mean global score was as follows: MRS 1ϭ0.62 (SDϭ0.22), MRS 2ϭ0.48 (SDϭ0.28), MRS 3ϭ0.27 (SDϭ0.24), MRS 4ϭ0.00 (SDϭ0.18), MRS 5ϭ Ϫ0.23 (SDϭ0.11). Worst mean single score was ambulation (0.29) and, subsequently cognition (0.49), and dexterity (0.58). CONCLUSIONS: Our results indicate the productive future for Japanese HUI3 use and showed precise measuring properties of the HUI3 Japanese version in assessing health status for stroke patients.
PCV74
ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTAN
